EUVIMEDEUVIMED entdecken
Crossref

Mechanism of Action of Tongjiang Mixture for Treating Reflux Esophagitis: A Study Using Serum Pharmacochemistry and Network Pharmacology

Yang Lu iD, Huang Yuzhen, Gu Yi, Wu Lili, Wang Yan, Tao Weiwei, Liu Wanli

Advanced Biology · 2025-01 · 9 (1)

DOI: 10.1002/adbi.202400187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 27.11.2024. Verfasst von Yang Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Pukou District Hospital of Traditional Chinese Medicine, Nanjing, 211899, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Esophagitis, Peptic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Natural Science Foundation of Nanjing University of Chinese Medicine, Nanjing Health Science and Technology Development Special Fund Project, Jiangsu Province Leading Talents Cultivation Project for Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tongjiang Mixture (TJM) is a traditional Chinese formula for treating reflux esophagitis (RE). Nevertheless, its active ingredients and potential pharmacological mechanisms are not yet clearly elucidated. This study will identify the active ingredients of TJM using serum pharmacochemistry and to elucidate the mechanism on RE through network pharmacology. The blood‐borne ingredients of TJM are identified by the Ultra‐performance liquid chromatography‐quadrupole‐time of flight‐mass spectrometer. Subsequently, a “compound‐target‐disease” network is established and obtained core targets associated with TJM and RE. Then, the potential signaling pathways are forecasted through the Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. Finally, the rat model of RE is established to verify the results predicted by network pharmacology through animal experiments. Fifteen blood‐borne ingredients of TJM are identified, with eight active ingredients‐namely Tangeretin, Tricin, Palmati, Berberine, Limonin, Evodiamine, Tetrahydropalmatine and Rutecarpine – making significant contributions to its efficacy. Moreover, TJM is predicted to act on 193 targets related to RE, involving AKT1, HSP90AA1, PIK3CA, and other targets, which enriches mainly in PI3K/AKT /NF‐κB signaling. Additionally, TJM can alleviate inflammation of the esophageal mucosa, reduce pathological damage, and increase gastric pH. It can downregulate PI3K, AKT, and NF‐κB mRNA transcription levels and reduce the protein expression of PI3K, AKT, and NF‐κB. Furthermore, it can inhibit the overproduction of IL‐6, TNF‐α and IL‐17. TJM can alleviate immune‐inflammatory responses and ameliorate RE by restraining the PI3K/AKT pathway and its downstream NF‐κB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalEsophagitis, PepticNetwork PharmacologyAnimalsRatsSignal TransductionMaleRats, Sprague-DawleyDisease Models, AnimalHumans

Stichwörter der Autor:innen

PI3K‐AKT/NF‐κB signalling pathwayTongjiang Mixturenetwork pharmacologyreflux esophagitisserum pharmacochemistry

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanjing Pukou District Hospital of Traditional Chinese Medicine, Nanjing, 211899, China.
  • Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210012, China.
  • Department of Gastroenterology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, 210028, China.
  • School Of Integrative Medicine NJUCM, Nanjing University of Chinese Medicine, Nanjing, 210023, China.

ORCID-Profile: Yang Lu

Förderung

  • Natural Science Foundation of Nanjing University of Chinese Medicine
  • Nanjing Health Science and Technology Development Special Fund Project
  • Jiangsu Province Leading Talents Cultivation Project for Traditional Chinese Medicine

Zitieren

APA

Lu, Y., Yuzhen, H., Yi, G., Lili, W., Yan, W., Weiwei, T., & Wanli, L. (2025). Mechanism of Action of Tongjiang Mixture for Treating Reflux Esophagitis: A Study Using Serum Pharmacochemistry and Network Pharmacology. Advanced Biology, 9(1). https://doi.org/10.1002/adbi.202400187

Vancouver

Lu Y, Yuzhen H, Yi G, Lili W, Yan W, Weiwei T, et al. Mechanism of Action of Tongjiang Mixture for Treating Reflux Esophagitis: A Study Using Serum Pharmacochemistry and Network Pharmacology. Advanced Biology. 2025;9(1). doi:10.1002/adbi.202400187

BibTeX
@article{Lu2025,
  author = {Lu, Yang and Yuzhen, Huang and Yi, Gu and Lili, Wu and Yan, Wang and Weiwei, Tao and Wanli, Liu},
  title = {Mechanism of Action of Tongjiang Mixture for Treating Reflux Esophagitis: A Study Using Serum Pharmacochemistry and Network Pharmacology},
  journal = {Advanced Biology},
  year = {2025},
  volume = {9},
  number = {1},
  doi = {10.1002/adbi.202400187}
}
Kostenlos starten →